Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2021 - Volume 25, Number 2
View All Articles in Issue

Abstract:  A formulation for preparing Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: eslicarbazepine acetate, formulation, anticonvulsant agent, seizure disorders, partial-onset seizures, children, adolescents

Related Categories: EXCIPIENTS, FORMULATIONS, PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4905

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products